aTyr Pharma Inc (NASDAQ: ATYR) stock enjoyed a major increase of 14.6% on 9/12/25. The shares closed at $6.03. Moreover, this advance was accompanied by exceptionally high trading volume at 323% of normal. The stock has risen 10.2% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
aTyr Pharma has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. aTyr Pharma has a very low Appreciation Score of 4 but a good Power Rating of 84, triggering the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment